FMC Stock Analysis — FMC Corporation
Sector: Chemicals
AI Verdict
At 5.6x forward earnings, you're getting a bargain only if FMC's moat can halt the -16.6% revenue slide; otherwise, the low multiple is a trap.
Competitive Moat
FMC develops crop protection chemicals with proprietary formulations and patents, giving it some insulation from generic competition. Its global distribution network and long-term relationships with large agribusinesses help defend market share even as generic pressure rises.
Summary
FMC trades at just 5.6x next year's earnings as the market digests a sharp -16.6% revenue drop.
Where It Stands
With a forward P/E of 5.6x, FMC is priced far below the chemicals sector median, but the -16.6% revenue decline signals real business headwinds.
Key Metrics
- Forward P/E: 5.6x
- Revenue Growth: -0.2%
- Dividend Yield: 0.03%
- 52-Week High: $44.28
- 52-Week Low: $10.72
Analyst Consensus
7 Buy · 14 Hold · 1 Sell (22 analysts)
Bull Case
A forward P/E of 5.6x is extremely cheap if FMC can stabilize after the -16.6% revenue drop, as any rebound could drive a rapid re-rating.
Bear Case
If earnings expectations reset lower to match the -16.6% revenue decline, even a low P/E could unwind quickly and erase any perceived value.
Catalyst to Watch
Watch for the next earnings report to see if revenue stabilizes or if guidance is cut again — either outcome will likely move the multiple.